Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives
Open Access
- 1 March 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 16 (3) , 457-462
- https://doi.org/10.1093/humrep/16.3.457
Abstract
Fragile X premutations are known to be a risk factor for diminished ovarian function at a relatively young age. We studied endocrine profiles of female fragile X family members (n = 79) at risk of premature ovarian failure (POF). Of these 79 women aged 40 IU/l, the threshold that defines POF. We confirmed that premutation carriers with menstrual cycles demonstrate premature ovarian dysfunction. However, we also found endocrine signs of unrecognized ovarian dysfunction in premutation carriers using oral contraceptives, despite endocrine alterations by oral contraceptives. Premutation carriers may have a poorer prognosis for future pregnancy, either achieved spontaneously or by assisted reproductive technology. We recommend that premutation carriers should be counselled not to wait too long if they wish to start a family.Keywords
This publication has 23 references indexed in Scilit:
- Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcomeHuman Reproduction, 2000
- Imprinting Effect in Premature Ovarian Failure Confined to Paternally Inherited Fragile X PremutationsAmerican Journal of Human Genetics, 2000
- Association between idiopathic premature ovarian failure and fragile X premutation.Human Reproduction, 2000
- Inhibin-B as a test of ovarian reserve for infertile women.Human Reproduction, 1999
- Fragile X premutation is a significant risk factor for premature ovarian failure: The international collaborative POF in fragile X study?preliminary dataAmerican Journal of Medical Genetics, 1999
- Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: A pilot studyAmerican Journal of Medical Genetics, 1999
- Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer.Human Reproduction, 1998
- Laboratory criteria for menopause in women using oral contraceptivesFertility and Sterility, 1996
- Further studies on pituitary and ovarian function in women receiving hormonal contraceptionContraception, 1981
- Pituitary and ovarian function in women receiving hormonal contraceptionContraception, 1979